Peter Rahmer - 13 Jan 2026 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role: Chief Corporate Development Officer
Signature: /s/ Soo-Yeun Lim, as Attorney-in-Fact
Issuer symbol: RLAY
Transactions as of: 13 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 15 Jan 2026, 16:13:45 UTC
Previous filing: 30 Oct 2025
Next filing: 29 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rahmer Peter	Chief Corporate Development Officer	C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE	/s/ Soo-Yeun Lim, as Attorney-in-Fact	15 Jan 2026	0001959229

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RLAY	Stock Option (Right to Buy)	Award	$0	+475,000		$0.000000	475,000	13 Jan 2026	Common Stock	475,000	$7.94	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 13, 2026, subject to the reporting person's continued service with the Issuer through each vesting date.

Remarks:

Chief Corporate Development Officer